Dodecyl Creatine Ester and Lipid Nanocapsule: A Double Strategy for the Treatment of Creatine Transporter Deficiency

• Stockler S , SchutzPW, SalomonsGS. Cerebral creatine deficiency syndromes. Clinical aspects, treatment and pathophysiology. Subcell. Biochem.46 , 149–166 (2007).
   PubMedGoogle Scholar
• Schulze A . Creatine deficiency syndromes. Mol. Cell. Biochem.244(1) , 143–150 (2003).
   PubMed Web of Science ®Google Scholar
• Degrauw TJ , CecilKM, ByarsAW, SalomonsGS, BallWS, JakobsC. The clinical syndrome of creatine transporter deficiency. Mol. Cell. Biochem.244(1–2) , 45–48 (2003).
   PubMed Web of Science ®Google Scholar
• Poo-Arguelles P , AriasA, Vilaseca Ma et al. X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J. Inherit. Metab. Dis.29(1) , 220–223 (2006).
   PubMed Web of Science ®Google Scholar
• Van De Kamp JM , PouwelsPJ, AarsenFK et al. Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J. Inherit. Metab. Dis. 35(1) , 141–149 (2012).
   PubMed Web of Science ®Google Scholar
• Ohtsuki S , TachikawaM, TakanagaH et al. The blood–brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J. Cereb. Blood Flow Metab.22(11) , 1327–1335 (2002).
   PubMed Web of Science ®Google Scholar
• Braissant O , HenryH, BeardE, UldryJ. Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino Acids40(5) , 1315–1324 (2011).
   PubMed Web of Science ®Google Scholar
• Lunardi G , ParodiA, PerassoL et al. The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience 142(4) , 991–997 (2006).
   PubMed Web of Science ®Google Scholar
• Trotier-Faurion A , DezardS, TaranF, ValayannopoulosV, De Lonlay P, Mabondzo A. Synthesis and biological evaluation of new creatine Fatty esters revealed dodecyl creatine ester as a promising drug candidate for the treatment of the creatine transporter deficiency. J. Med. Chem.56(12) , 5173–5181 (2013).
   PubMed Web of Science ®Google Scholar
• Lamprecht A , BouligandY, BenoitJP. New lipid nanocapsules exhibit sustained release properties for amiodarone. J. Control. Release84(1–2) , 59–68 (2002).
   PubMed Web of Science ®Google Scholar
• Laine AL , HuynhNT, ClavreulA et al. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules. Eur. J. Pharm. Biopharm. 81(3) , 690–693 (2012).
   PubMed Web of Science ®Google Scholar
• Huynh NT , PassiraniC, SaulnierP, BenoitJP. Lipid nanocapsules: a new platform for nanomedicine. Int. J. Pharm.379(2) , 201–209 (2009).
   PubMed Web of Science ®Google Scholar
• Roger E , LagarceF, BenoitJP. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur. J. Pharm. Biopharm.79(1) , 181–188 (2011).
   PubMed Web of Science ®Google Scholar
• Lacombe O , VideauO, ChevillonD et al. In vitro primary human and animal cell-based blood–brain barrier models as a screening tool in drug discovery. Mol Pharm8(3) , 651–663 (2011).
   PubMedGoogle Scholar
• Heurtault B , SaulnierP, PechB, ProustJE, BenoitJP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res.19(6) , 875–880 (2002).
   PubMed Web of Science ®Google Scholar
• Brun E , CarriereM, MabondzoA. In vitro evidence of dysregulation of blood–brain barrier function after acute and repeated/long-term exposure to TiO(2) nanoparticles. Biomaterials33(3) , 886–896 (2012).
   Google Scholar
• Valayannopoulos V , BakouhN, MazzucaM et al. Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome. J. Inherit. Metab. Dis. 36(1) , 103–112 (2013).
   PubMed Web of Science ®Google Scholar
• Valayannopoulos V , BoddaertN, ChabliA et al. Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J. Inherit. Metab. Dis. 35(1) , 151–157 (2012).
   PubMed Web of Science ®Google Scholar
• Skelton M r, Schaefer Tl, Graham Dl et al. Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS ONE6(1) , e16187 (2011).
   PubMedGoogle Scholar

Patent

• Dezard D, Taran F, Trotier-Faurion A, Mabondzo A: EP-2692719A1 (2014).
   Google Scholar